Gain Therapeutics (GANX) EBT (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly EBT of -$5.4 million for Q1 2026, down 22.49% year-over-year from -$7.0 million in Q1 2025, and down 21.45% quarter-over-quarter from -$4.5 million in Q4 2025.
Gain Therapeutics (GANX) EBT (2020 - 2026) Analysis & Trends
Gain Therapeutics' EBT history runs 7 years deep, the most recent figure standing at -$5.4 million for Q1 2026.
- In Q1 2026, EBT fell 22.49% year-over-year to -$5.4 million; the TTM figure through Mar 2026 stood at -$20.3 million (changed 0.07% YoY), while the FY2025 annual figure was -$19.3 million, up 2.89% from the prior year.
- EBT for Q1 2026 stood at -$5.4 million, down from -$4.5 million in the prior quarter.
- The five-year high for EBT was $12.7 million in Q4 2022, with the low at -$8.1 million in Q2 2024.
- The 5-year median for EBT is -$4.7 million (2023), against an average of -$4.0 million.
- The sharpest annual moves came in 2022 and 2023: EBT soared 494.82% in 2022, then tumbled 139.22% in 2023.
- Gain Therapeutics' EBT stood at $12.7 million in 2022, then tumbled by 139.22% to -$5.0 million in 2023, then jumped by 34.72% to -$3.3 million in 2024, then slumped by 36.89% to -$4.5 million in 2025, then declined by 21.45% to -$5.4 million in 2026.
- Business Quant data shows GANX's EBT at -$5.4 million in Q1 2026, -$4.5 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Gain Therapeutics | 85.12 Mn | 85.12 Mn | - | -4.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.57 Mn |
| Mar 31, 2026 | -5.43 Mn |
| Dec 31, 2025 | -4.47 Mn |
| Sep 30, 2025 | -4.74 Mn |
| Jun 30, 2025 | -5.67 Mn |
| Mar 31, 2025 | -4.43 Mn |
| Dec 31, 2024 | -3.26 Mn |
| Sep 30, 2024 | -4.47 Mn |
| Jun 30, 2024 | -8.14 Mn |
| Mar 31, 2024 | -3.99 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Sep 30, 2023 | -4.70 Mn |
| Jun 30, 2023 | -7.66 Mn |
| Mar 31, 2023 | -5.12 Mn |
| Dec 31, 2022 | 12.75 Mn |
| Sep 30, 2022 | -4.55 Mn |
| Jun 30, 2022 | -5.08 Mn |
| Mar 31, 2022 | -3.27 Mn |
| Dec 31, 2021 | -3.23 Mn |
| Sep 30, 2021 | -4.66 Mn |